Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.
about
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.Smoking adversely affects survival in acute myeloid leukemia patientsAllogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomeTolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA TrialPharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.Reduced-intensity conditioned allogeneic SCT in adults with AML.Alemtuzumab in allogeneic hematopoetic stem cell transplantation.Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation.Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromeAllogeneic stem cell transplantation for acute myeloid leukemia.Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients.Redefining transplant in acute leukemia.Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion.Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study.T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipientsCompeting-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects
P2860
Q34049208-FB526AD6-1C21-452E-841B-882E8A008C84Q34325183-1E7464C5-862C-4F2A-A165-2EE6A5E3229CQ35449042-6EB99815-D11C-425A-8E96-F931874AF637Q35925072-2381417D-71E9-48EE-9946-0A2076A959ABQ36506169-E6F0B27C-EED7-4420-9B24-DE3467845904Q36980277-DD95B8B2-4BC5-4E69-9641-60AD747C2032Q37216476-88619686-74C6-41E6-8406-A2F48C4E0899Q38366632-744739C8-E90A-4755-9CDB-4C1E507C2676Q42149544-43F5FF50-2296-439C-9FF7-CA15B474C987Q42432554-4318011E-4832-4960-A2B8-4139962CA319Q42765063-79264E89-0D52-47C0-AF80-A87A9BF66678Q42765065-71B02795-D738-4AEC-9E5F-7EA5FBFF41E6Q44477117-AD2767C6-9F2C-432D-BDEA-8C7C96C901E7Q44657508-C8609F47-CFDC-4D6D-9C87-0523FEF6BCBBQ44973890-2A693589-53FB-4411-BD38-D079FF63FA73Q45716180-BB2878E0-F0FA-4C58-8690-1869C9E57A0CQ52838715-9713D5FA-2A55-4751-A9D2-755AEE328287Q58449860-C027F339-0608-435B-81E9-1521DA8BBC71Q58776904-A31D5838-23BF-4592-B52D-258D955ACD14
P2860
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Factors predicting long-term s ...... on for acute myeloid leukemia.
@ast
Factors predicting long-term s ...... on for acute myeloid leukemia.
@en
type
label
Factors predicting long-term s ...... on for acute myeloid leukemia.
@ast
Factors predicting long-term s ...... on for acute myeloid leukemia.
@en
prefLabel
Factors predicting long-term s ...... on for acute myeloid leukemia.
@ast
Factors predicting long-term s ...... on for acute myeloid leukemia.
@en
P2093
P2860
P50
P1433
P1476
Factors predicting long-term s ...... on for acute myeloid leukemia.
@en
P2093
Andrew Peniket
Cassandra Brookes
Donald Milligan
Effie Liakopoulou
Eleni Tholouli
Emmanouil Nikolousis
Fiona Clark
Gordon Cook
John Snowden
P2860
P304
P356
10.3324/HAEMATOL.2009.013920
P577
2009-11-30T00:00:00Z